Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
trametinib dual specificity mitogen-activated protein kinase kinase 1 small molecule NA drugbank , DGIDB Mutation[MeSHID:D009154]
melanoma[MeSHID:D008545]
Anaplastic thyroid carcinoma[MeSHID:D065646]
Severe Acute Respiratory Syndrome[MeSHID:D045169]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Middle East Respiratory Syndrome[MeSHID:D018352]		 0.67 approved antagonist,inhibitor
trametinib dual specificity mitogen-activated protein kinase kinase 1 small molecule NA drugbank , DGIDB Mutation[MeSHID:D009154]
melanoma[MeSHID:D008545]
Anaplastic thyroid carcinoma[MeSHID:D065646]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.67 approved antagonist,inhibitor
trametinib dual specificity mitogen-activated protein kinase kinase 2 small molecule NA drugbank , DGIDB Mutation[MeSHID:D009154]
melanoma[MeSHID:D008545]
Anaplastic thyroid carcinoma[MeSHID:D065646]
Severe Acute Respiratory Syndrome[MeSHID:D045169]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Middle East Respiratory Syndrome[MeSHID:D018352]		 0.3 approved antagonist,inhibitor
trametinib dual specificity mitogen-activated protein kinase kinase 2 small molecule NA drugbank , DGIDB Mutation[MeSHID:D009154]
melanoma[MeSHID:D008545]
Anaplastic thyroid carcinoma[MeSHID:D065646]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.3 approved antagonist,inhibitor
click here to return to the previous page